Elevated levels of the Kearns-Sayre syndrome mitochondrial DNA deletion in temporal cortex of Alzheimer's patients

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 379, Issue 2, 1997, Pages 253-262

  Hamblet, Natasha S ^a   Castora, Frank J ^a  

^a EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

Author keywords

Alzheimer's disease; Deleted mitochondrial DNA; Kearns Sayre syndrome

Indexed keywords

MITOCHONDRIAL DNA;

AGED; ALZHEIMER DISEASE; ANIMAL TISSUE; ARTICLE; AUTOPSY; CONTROLLED STUDY; GENE DELETION; HUMAN; HUMAN TISSUE; KEARNS SAYRE SYNDROME; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RAT; TEMPORAL CORTEX;

AGE FACTORS; AGED; ALZHEIMER DISEASE; ANIMALS; DNA, MITOCHONDRIAL; HUMANS; KEARNS-SAYER SYNDROME; MIDDLE AGED; OXIDATIVE PHOSPHORYLATION; POLYMERASE CHAIN REACTION; POSTMORTEM CHANGES; RATS; RATS, SPRAGUE-DAWLEY; SEQUENCE DELETION; TEMPORAL LOBE; TIME FACTORS;

EID: 0031556536     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0027-5107(97)00158-9     Document Type: Article

References (57)

1. Goate A., Chartier-Harlin M.C., Mullan M., Brown J., Crawford F., Fidani L., Guiffra L., Haynes A., Irving N., James L., Mant R., Newton P., Rooke K., Roques P., Talbot C., Williamson R., Rossor M., Owen M., Hardy J. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature. 349:1991;704-706.
2. Naruse S., Igarashi S., Kobayashi H., Aoki K., Inuzuka K., Shimizu T., Iihara K., Kojima T., Miyatake T.et al. Missense mutation val→ile in exon 17 of amyloid precursor protein gene in Japanese familial Alzheimer's disease. Lancet. 37:1991;978-979.
3. Sherrington R., Rogeav E.I., Liang Y., Rogeav E.A., Levesque G., Ikeda M., Chi H., Lin C., Li G., Holman K., Sorbi S., Raincro I., Pinessi L., Nee L., Chumakov I., Pollen D., Brookes A., Sanseau P., Polinsky R., Wasco W., DaSilva H., Haines J., Pericak-Vance M., Tanzi R., Roses A., Fraser P., Rommas J., St. George-Hyslop P. Cloning of a gene bearing missense mutations in early onset familial Alzheimer's disease. Nature. 375:1995;754-760.
4. Robinson P.A., Leek J.P., Thompson J., Carr I.M., Bailey A., Moynihan T.P., Coletta P.L., Lench N.J., Markham A.F. A human ubiquitin conjugating enzyme, L-UBC, maps in the Alzheimer's disease locus on chromosome 14q24.3. Mamm. Genome. 6:1995;725-731.
5. Saunders A.M., Strittmatter W.J., Schmechel D. Association of apolipoprotein E allele ε4 with late onset familial and sporadic Alzheimer's Disease. Neurology. 43:1993;1467-1472.
6. Metter E.J., Riege W.H., Benson D.F., Kuhl D.E., Phelps M.E. Patterns of regional cerebral glucose metabolism in Alzheimer's disease patients. Neurol. Neurobiol. 18:1985;35-47.
7. 14C]glucose in vitro in human neocortex. J. Neurochem. 41:1983;1329-1334.
8. Sorbi S., Bird E.D., Blass J.P. Decreased pyruvate dehydrogenase complex activity in Huntington's and Alzheimer's brain. Ann. Neurol. 13:1983;72-78.
9. Peterson C., Goldman J.E. Alterations in calcium content and biochemical processes in cultured skin fibroblasts from aged and Alzheimer donors. Proc. Natl. Acad. Sci. USA. 83:1986;2758-2762.
10. Sims N.R., Finnegan J.M., Blass J.P. Altered metabolic properties of cultured skin fibroblasts in Alzheimer's disease. Ann. Neurol. 21:1987;451-457.
11. Gibson G.E., Sheu K., Blass J.P. Reduced activities of thiamine dependent enzymes in the brains and peripheral tissues of patients with Alzheimer's Disease. Arch. Neurol. 45:1988;836-840.
12. Mariani C., Bresolin N., Moggio M., Ferrante C., Ciafaloni E., Sertorelli S., Ciccone A., Scarlato G. Muscle biopsy in Alzheimer's disease: morphological and biochemical findings. Clin. Neuropathol. 10:1991;171-176.
13. Blass J.P., Baker A.C., Ko L., Black R.S. Induction of Alzheimer antigens by an uncoupler of oxidative phosphorylation. Arch. Neurol. 47:1990;864-869.
14. Gabuzda D., Busciglio J., Chen L.B., Matsudaira P., Yankner B.A. Inhibition of energy metabolism alters the processing of amyloid precursor protein and induces a potentially amyloidogenic derivative. J. Biol. Chem. 269:1994;13623-13628.
15. Shoffner J., Lott M.J., Lezza A.M.S., Seibel P., Ballinger S.W., Wallace D.C. Myoclonic epilepsy and ragged red fiber disease (MERRF) is associated with a mitochondrial tRNA Lys mutation. Cell. 61:1990;931-937.
16. Goto Y., Nonaka I., Horai S. A mutation in the tRNA Leu (UUR) gene is associated with the MELAS subgroup of mitochondrial encephalomyopathies. Nature. 348:1990;651-653.
17. Wallace D.C., Singh G., Lott M.T., Hodge J.A., Schurr T.G., Lezza A.M., Elsas L.J., Nikoskelainen E.K. Mitochondrial DNA mutation associated with Lebers hereditary optic neuropathy. Science. 242:1988;1427-1430.
18. Holt I.J., Harding A.E., Petty R.K.H., Morgan-Hughes J.A. A new mitochondrial disease associated with mitochondrial DNA heteroplasmy. Am. J. Hum. Genet. 46:1990;428-433.
19. Holt I.J., Harding A.E., Morgan-Hughes J.A. Deletions of muscle mitochondrial DNA in patients with mitochondrial myopathies. Nature. 331:1988;717-719.
20. Schon E.A., Rizzuto R., Moraes C.T., Nakase H., Zeviani M., Dimauro S. A direct repeat is a hotspot for large-scale deletion of human mitochondrial DNA. Science. 244:1989;346-349.
21. Shoffner J.M., Lott M.T., Voljavec A.S., Soueidan S.A., Costigan D.A., Wallace D.C. Spontaneous Kearns-Sayre/chronic external ophthalmoplegia plus syndrome associated with a mitochondrial deletion: a slip replication model and metabolic therapy. Proc. Natl. Acad. Sci. USA. 86:1989;7952-7956.
22. Beal M.F. Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses? Ann. Neurol. 31:1992;119-130.
23. Veltri K., Espiritu M., Singh G. Distinct genomic copy number in mitochondria of different mammalian organs. J. Cell. Physiol. 143:1990;160-164.
24. Gibson G.E., Peterson C.P. Aging decreases oxidative metabolism and the release and synthesis of acetylcholine. J. Neurochem. 37:1981;978-984.
25. Luft R. The development of mitochondrial medicine. Proc. Natl. Acad. Sci. USA. 91:1994;8731-8738.
26. Shoffner J.M., Brown M.D., Torroni A., Lott M.T., Cabell M.F., Mirra S.S., Beal M.F., Yang C.C., Gearing M., Salvo R.et al. Mitochondrial DNA variants observed in Alzheimer disease and Parkinson disease patients. Genomics. 17:1993;171-184.
27. Hutchin T., Cortopassi G. A mitochondrial DNA clone is associated with increased risk for Alzheimer disease. Proc. Natl. Acad. Sci. USA. 92:1995;6892-6895.
28. Brown M.D., Shoffner J.M., Kim Y.L., Jun A.S., Graham B.H., Cabell M.F., Gurley D.S., Wallace D.C. Mitochondrial DNA sequence analysis of four Alzheimer's and Parkinson's disease patients. Am. J. Med. Genet. 61:1996;283-289.
29. Davis R.E., Miller S., Herrnstadt C., Ghosh S.S., Fahy E., Shinobu L.A., Galasko D., Thal L.J., Beal M.F., Howell N., Parker W.D. Jr. Mutations in mitochondrial cytochrome c oxidase genes segregate with late-onset Alzheimer disease. Proc. Natl. Acad. Sci. USA. 94:1997;4525-4531.
30. Cortopassi G., Arnheim N. Detection of mitochondrial DNA deletion in tissues of older humans. Nucleic Acids Res. 18:1990;6927-6933.
31. Hattori K., Tanaka M., Sugiyama S., Obayashi T., Ito T., Satake T., Hanaki Y., Asai J., Nagano M., Ozawa T. Age-dependent increase in deleted mitochondrial DNA in the human heart: possible contributory factor to presbycardia. Am. Heart J. 6:1991;1735-1742.
32. Katayama M., Tanaka M., Yamamoto H., Ohbayashi T., Nimura Y., Ozawa T. Deleted mitochondrial DNA in the skeletal muscle of aged individuals. Biochem. Int. 25:1991;47-56.
33. Yen C., Su J., King K., Wei Y. Ageing-associated 5kb deletion in human liver mitochondrial DNA. Biochem. Biophys. Res. Commun. 178:1991;124-131.
34. Cortopassi G.A., Shibata D., Soong N.W., Arnheim N. A pattern of accumulation of a somatic deletion of mitochondrial DNA in aging human tissues. Proc. Natl. Acad. Sci. USA. 89:1992;7370-7374.
35. Yen T., Pang C., Hsieh R., Su C., King K., Wei Y. Age-dependent 6 kb deletion in human liver mitochondrial DNA. Biochem. Int. 26:1992;457-468.
36. Blanchard B.J., Park T., Fripp W.J., Lerman L.S., Ingram V.M. A mitochondrial DNA deletion in normally aging and in Alzheimer brain. Neuroreport. 4:1993;799-802.
37. Corral-Debrinski M., Horton T., Lott M., Shoffner J., McKee A., Beal M., Graham B., Wallace D. Marked changes in mitochondrial DNA deletion levels in Alzheimer brains. Genomics. 23:1994;471-476.
38. Swierczynski J., Scislowski O., Aleksandrowicz Z. High activity of alpha glycerophosphate oxidation by human placental mitochondria. Biochim. Biophys. Acta. 429:1976;46-54.
39. Drouin J. Cloning of human mitochondrial DNA in Escherichia coli. J. Mol. Biol. 140:1980;15-34.
40. Southern E.M. Detection of specific sequences among DNA fragments separated by gel electrophoresis. J. Mol. Biol. 98:1975;503-517.
41. D.K. Wright, M.M. Manos, Sample preparation from paraffin-embedded tissue, in: M.A. Innis, D.H. Gelfand, J.J. Sninsky, T.J. White (Eds.), PCR Protocols: A Guide to Methods and Applications, Academic Press, New York, 1990, p. 153.
42. Anderson S., Bankier A.T., Barrell B.G., deBruijn M., Coulson A.R., Drouin J., Eperon I., Nierlich D., Roe B., Sanger F., Schreier P., Smith A., Staden R., Young I.G. Sequence and organization of the human mitochondrial genome. Nature. 290:1981;457-465.
43. J.S. Chamberlain, R.A. Gibbs, J.E. Ranier, C.T. Caskey, Multiplex PCR for the diagnosis of Duchenne muscular dystrophy, in: M.A. Innis, D.H. Gelfand, J.J. Sninsky, T.J. White (Eds.), PCR Protocols: A Guide to Methods and Applications, Academic Press, New York, 1990, pp. 272-281.
44. Corral-Debrinski M., Stepien G., Shoffner J.M., Lott M.T., Kanter K., Wallace D.C. Hypoxemia is associated with mtDNA damage and gene induction: Implications for cardiac arrest. J. Am. Med. Assoc. 266:1991;1812-1816.
45. Hamblet N.S., Castora F.J. Mitochondrial DNA deletion analysis: a comparison of PCR quantitative methods. Biochem. Biophys. Res. Commun. 207:1995;839-847.
46. Corral-Debrinski M., Horton T., Lott M.T., Shoffner J.M., Beal M.F., Wallace D.C. Mitochondrial DNA deletions in human brain: regional variability and increase with advanced age. Nature Genet. 2:1992;324-329.
47. Sheu K.R., Chen X., Schon E.A. Are there deletions of mitochondrial DNA in Alzheimer's disease? Neurology. 44:1994;A390.
48. Wei Y. Mitochondrial DNA alterations as ageing-associated molecular events. Mutation Res. 275:1992;145-155.
49. E.A. Schon, MtDNA and the genetics of mitochondrial disease, in: A.H.V. Schapira, S. DiMauro (Eds.), Mitochondrial Disorders in Neurology, Butterworth-Heinemann, Oxford, UK, 1994, pp. 31-48.
50. Corbisier P., Remacle J. Involvement of mitochondria in cell degeneration. Eur. J. Cell. Biol. 51:1990;173-182.
51. Hayashi J., Ohta S., Kikuchi A., Takemitsu M., Goto Y., Nonaka I. Introduction of disease related mitochondrial DNA deletions in Hela cells lacking mitochondrial DNA results in mitochondrial dysfunction. Proc. Natl. Acad. Sci. USA. 88:1991;10614-10618.
52. Parker W. Jr., Parks J., Filley C., Kleinschmidt-DeMasters B.K. Electron transport chain defects in Alzheimer's disease brain. Neurology. 44:1994;1090-1096.
53. Roder H.M., Ingram V.M. Two novel kinases phosphorylate tau and the KSP site of heavy neurofilament subunits in high stoichiometric ratios. J. Neurosci. 11:1991;3325-3343.
54. Miquel J. An update on the mitochondrial-DNA mutation hypothesis of cell aging. Mutation Res. 275:1992;209-216.
55. Meococci P., MacGarvey U., Beal M.F. Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease. Ann. Neurol. 36:1994;747-751.
56. Harman D. The biologic clock: the mitochondria? J. Am. Geriatr. Soc. 20:1972;145-147.
57. Dyrks T., Dyrks E., Hartman T., Masters C., Beyreuther K. Amyloidogenicity of bA4 and bA4-bearing amyloid protein precursor fragments by metal catalyzed oxidation. J. Biol. Chem. 267:1992;18210-18217.